Protocol summary

Study aim
Comparing of programmed intermittent epidural bolus with continuous epidural infusion in labor analgesia with solution of Dexmedetomidine and Rupivacaine
Design
Clinical trial, with parallel groups, double-blind, randomized, phase 2-3 on 60 patients. In order to randomize, the block randomization method will be used.
Settings and conduct
In Akbarabadi Hospital, women with a gestational age greater than or equal to 37 weeks will be enrolled to the study. Patients will be randomly divided into 2 groups based on Blocks with size 6. The sample size for each study group is 30. A total of 60 patients will be examined. Patientsو surgeons and data analyzer will be blind.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Term women with gestational age 37 weeks or more, Cervical dilation Larger than 4 cm, Spontaneous or induced labor pain, Applying for epidural analgesia, Weight 55 to 85 kg. Exclusion criteria: History of sever cardiovascular diseases, Contraindication of epidural analgesia, Patients that are candidate for cesarean section ( multiple pregnancy , gestational age more than 37 weeks, preeclampsia , etc ), Patient discontent, Opium addiction, Height less than 150 cm
Intervention groups
In the first intervention group: with programmed intermittent epidural bolus, bolus dose of 8cc of the solution will be administered every 60 minutes regularly. In the second intervention group: with continuous epidural infusion, infusion of 8 cc/hr of the solution consumption as maintenance after loading dose will be administered continuously by an infusion pomp.
Main outcome variables
Degree of reduced labor pain and pain relief maternal satisfaction; Total analgesic solution consumption; Apgar score; Side effects and hemodynamic changes

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20210405050851N1
Registration date: 2021-10-30, 1400/08/08
Registration timing: prospective

Last update: 2021-10-30, 1400/08/08
Update count: 0
Registration date
2021-10-30, 1400/08/08
Registrant information
Name
golnoosh khosravian
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2243 4717
Email address
desdemona_wsh@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-11-06, 1400/08/15
Expected recruitment end date
2022-02-19, 1400/11/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparing of programmed intermittent epidural bolus (PIEB) with continuous epidural infusion (CEI) for labor analgesia in patients receiving epidural dexmedetomidine and Rupivacaine
Public title
Comparing of programmed intermittent epidural bolus with continuous epidural infusion for labor analgesia
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Term woman with gestational age 37 weeks or more Cervical dilation Larger than 4 cm Spontaneous or induced labor pain Applying for epidural analgesia Weight 55 to 85 kg
Exclusion criteria:
Patients with past medical history of sever cardiovascular diseases and bradycardia Contraindication of epidural analgesia Patients that are candidate for cesarean section ( multiple pregnancy , gestational age more than 37 weeks, preeclampsia , etc ) Patient discontent Opium addiction Height less than 150 cm
Age
From 18 years old to 45 years old
Gender
Female
Phase
2-3
Groups that have been masked
  • Participant
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Patients will be randomly assigned to tree groups by using a random number table. In order to randomize, a random block method will be used. For this purpose, we formed blocks of size 6. In each block, 3 individuals will be in first intervention group and 3 will be in second intervention group. A total of 10 blocks will be considered for the study.
Blinding (investigator's opinion)
Double blinded
Blinding description
Surgeons and patients will be kept blind and unaware of the type of labor analgesia . Patients will be aware that they will be randomly assigned to one of two treatment groups, but will be unaware of which analgesic method will be provided in that group. Patients will be assigned to one of two groups using random number tables. The surgeon also knows that patients will be anesthetized in two different ways, but will not know which procedure will be performed for each patient. The data collection officer, analyst and outcome assessor will collect and analyze information based on groups 1 and 2 and will not be aware of the type of type of analgesia presented in the groups. They will be kept blind.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Science
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Approval date
2020-09-19, 1399/06/29
Ethics committee reference number
IR.IUMS.FMD.REC.1399.397

Health conditions studied

1

Description of health condition studied
Epidural labor analgesia
ICD-10 code
O74.6
ICD-10 code description
Other complications of spinal and epidural anesthesia during labor and delivery

Primary outcomes

1

Description
Maternal satisfaction of labor analgesia
Timepoint
At the end of labor
Method of measurement
Visual analogue scale

2

Description
Total dose of Dexmedetomidine using in the end of labor
Timepoint
At the end of labor
Method of measurement
Based on checklist - in milliliters

3

Description
Total dose of Rupivacain using in the end of labor
Timepoint
At the end of labor
Method of measurement
Based on checklist - in milliliters

Secondary outcomes

1

Description
New born Infant Apgar score
Timepoint
In the first and fifth minute after fetal delivery
Method of measurement
Apgar score

2

Description
Infant Arterial Blood Gas
Timepoint
Five minutes after fetal delivery
Method of measurement
Umbilical cord arterial blood

3

Description
Incidence rate of instrumental delivery
Timepoint
The last stage of delivery
Method of measurement
Record in the end of labor

4

Description
Duration of delivery
Timepoint
Duration of delivery from the time of patient entrance in the labor until the time of fetal delivery
Method of measurement
Based on checklist - minute unit

5

Description
Side effects including nausea, vomiting, itching, decrease blood pressure, bradycardia
Timepoint
From the loading dose of epidural analgesia every hour till the end of labor
Method of measurement
Patient's sign and symptoms and record in the checklist

6

Description
Incidence rate of motor block
Timepoint
From the beginning of Epidural analgesia every hour till the end of labor
Method of measurement
Bromage score (0- 1- 2- 3)

Intervention groups

1

Description
Intervention group 1: Term women with gestational age 37 weeks or more who have entrance condition to the study, amount of 3cc test dose of Dexmedetomidine 0.5µg/ml and Rupivacain %0.1 will be administered and after 5 minutes, amount of 8cc from the same solution as loading dose will be administered. then in the group programmed intermittent epidural bolus, bolus dose of 8cc of the solution will be administered every 60 minutes regularly.
Category
Treatment - Drugs

2

Description
Intervention group 2: Term women with gestational age 37 weeks or more who have entrance condition to the study, amount of 3cc test dose of Dexmedetomidine 0.5µg/ml and Rupivacain %0.1 will be administered and after 5 minutes, amount of 8cc from the same solution as loading dose will be administered. in the continuous epidural infusion group, infusion of 8 cc/hr of the solution consumption as maintenance after loading dose will be administered continuously by an infusion pomp.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Shahid Akbarabadi hospital
Full name of responsible person
Golnoosh Khosravian
Street address
Baghferdos station., Molavi Ave
City
tehran
Province
Tehran
Postal code
1168743514
Phone
+98 21 5560 6034
Email
akbarabadihosp@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Hossein Keyvani
Street address
Iran Medical University., Hemmat highway
City
Tehran
Province
Tehran
Postal code
1449614536
Phone
+98 21 8670 1021
Email
research-m@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Golnoosh Khosravian
Position
Anesthesiology Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No. 2, Dead end Aghaghia., South Makouyipour Ave., Behzadi Ave.,13th East Velenjak Ave
City
Tehran
Province
Tehran
Postal code
1987733373
Phone
+98 21 2243 4717
Email
desdemona_wsh@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Golnoosh Khosravian
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No. 2, Dead end Aghaghia., South Makouyi pour Ave., Behzadi Ave., 13thEast Velenjak Ave
City
Tehran
Province
Tehran
Postal code
1987733373
Phone
+98 21 2243 4717
Email
desdemona_wsh@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Golnoosh Khosravian
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No. 2, Dead end Aghaghia., South Makouyi pour Ave., Behzadi Ave., 13thEast Velenjak Ave
City
Tehran
Province
Tehran
Postal code
1987733373
Phone
+98 21 2243 4717
Email
desdemona_wsh@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...